Elevation of soluble interleukin-2 receptor levels in the bronchoalveolar lavage from patients with systemic sclerosis

Rheumatology International

Volumn 21, Issue 3, 2001, Pages 122-126

  Martinez, J A B ^a   Guatura, C N S B ^a   King, E S T E ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bronchoalveolar lavage; Interstitial lung disease; Soluble interleukin 2 receptor; Systemic sclerosis

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG LAVAGE; LUNG SCINTISCANNING; LYMPHOCYTE; MALE; NEUTROPHIL; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC SCLEROSIS;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; FEMALE; HUMANS; INTERLEUKIN-2; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; RECEPTORS, INTERLEUKIN-2; SCLERODERMA, SYSTEMIC; SOLUBILITY;

EID: 0035170141     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-001-0147-x     Document Type: Article

References (23)

1. Mortality in systemic sclerosis (scleroderma)
2. Epidemiology of rheumatic disease: Systemic sclerosis
3. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage: Relationship between alveolitis and subsequent changes in lung function
4. Evaluation of alveolitis by studies of lung biopsies
5. Usual interstitial pneumonitis is a T-cell alveolitis
6. Fibrosing alveolitis in systemic sclerosis: Increase in memory T-cells in lung interstitium
7. Production of type 2 cytokines by CD8 + lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis
8. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
9. Valores de referência para espirometria em uma amostra da população brasileira adulta
10. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups
11. Classification, prognosis
12. Structural features of interstitial lung disease in systemic sclerosis
13. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: A quantitative study of open lung biopsies
14. 99mTc-DTPA clearance
15. Pulmonary involvement in progressive systemic sclerosis: Sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage
16. Pulmonary involvement in diffuse cutaneous systemic sclerosis: Bronchoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis
17. Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease
18. The soluble interleukin-2 receptor: Biology, function, and clinical application
19. Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma. Effect of chlorambucil
20. Soluble interleukin-2 receptors in patients with systemic sclerosis
21. Soluble serum interleukin 2 receptors in patients with systemic sclerosis
22. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung
23. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis